Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan S Go

Showing results (81-90 of 571) with videos related to

Pageof 58
Sort By:
The American Journal of Cardiology|September 17, 2013
Effectiveness and safety of spironolactone for systolic heart failureKeane K Lee, David Shilane, Mark A Hlatky, et al.
The Permanente Journal|March 3, 2016
Association of Age to Mortality and Repeat Revascularization in End-Stage Renal Disease Patients: Implications for Clinicians and Future Health PoliciesAshok Krishnaswami, Thomas Alloggiamento, Daniel E Forman, et al.
Journal of the American College of Cardiology|February 26, 2008
Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillationMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
Journal of the American Society of Nephrology : JASN|July 22, 2005
Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled studyJuan Carlos Ayus, M Reza Mizani, Steven G Achinger, et al.
BMC Cardiovascular Disorders|July 20, 2017
Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000-2015Stephen Sidney, Charles P Quesenberry, Marc G Jaffe, et al.
Journal of the American College of Cardiology|December 19, 2012
Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary interventionMark A Hlatky, Matthew D Solomon, David Shilane, et al.
Circulation|January 1, 2013
Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney diseaseNisha Bansal, Dongjie Fan, Chi-yuan Hsu, et al.
Obstetrics and Gynecology|August 24, 2011
Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomesErica P Gunderson, Lisa A Croen, Vicky Chiang, et al.
Kidney International|October 14, 2005
The conundrum of increased burden of end-stage renal disease in AsiansYoshio N Hall, Chi-yuan Hsu, Carlos Iribarren, et al.
Journal of the American College of Cardiology|December 20, 2014
Reply: Beta-blockers for angina: time to reassess the specific impact of drug therapy in coronary heart disease patientsMark A Hlatky, Charlotte Andersson, Tara I Chang, et al.
Pageof 58

Showing results (81-90 of 571) with videos related to

Sort By:
Pageof 58
The American Journal of Cardiology|September 17, 2013
Effectiveness and safety of spironolactone for systolic heart failureKeane K Lee, David Shilane, Mark A Hlatky, et al.
The Permanente Journal|March 3, 2016
Association of Age to Mortality and Repeat Revascularization in End-Stage Renal Disease Patients: Implications for Clinicians and Future Health PoliciesAshok Krishnaswami, Thomas Alloggiamento, Daniel E Forman, et al.
Journal of the American College of Cardiology|February 26, 2008
Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillationMargaret C Fang, Alan S Go, Yuchiao Chang, et al.
Journal of the American Society of Nephrology : JASN|July 22, 2005
Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled studyJuan Carlos Ayus, M Reza Mizani, Steven G Achinger, et al.
BMC Cardiovascular Disorders|July 20, 2017
Heterogeneity in national U.S. mortality trends within heart disease subgroups, 2000-2015Stephen Sidney, Charles P Quesenberry, Marc G Jaffe, et al.
Journal of the American College of Cardiology|December 19, 2012
Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary interventionMark A Hlatky, Matthew D Solomon, David Shilane, et al.
Circulation|January 1, 2013
Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney diseaseNisha Bansal, Dongjie Fan, Chi-yuan Hsu, et al.
Obstetrics and Gynecology|August 24, 2011
Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomesErica P Gunderson, Lisa A Croen, Vicky Chiang, et al.
Kidney International|October 14, 2005
The conundrum of increased burden of end-stage renal disease in AsiansYoshio N Hall, Chi-yuan Hsu, Carlos Iribarren, et al.
Journal of the American College of Cardiology|December 20, 2014
Reply: Beta-blockers for angina: time to reassess the specific impact of drug therapy in coronary heart disease patientsMark A Hlatky, Charlotte Andersson, Tara I Chang, et al.
Pageof 58